BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma

BACKGROUND: High-dose chemotherapy followed by autologous hematopoietic stem cell transplant has proven useful in relapsed or refractory cases of Hodgkin and non-Hodgkin lymphoma. BEAM (carmustine, etoposide, cytarabine, melphalan) is frequently used as a conditioning regimen; however, the high cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Ron-Magaña, Ana Lucia, Fernandez-Vargas, Omar Eduardo, Barrera-Chairez, Esperanza, Ron-Guerrero, Carlos Silvestre, Bañuelos-Ávila, Ana Jaqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824191/
https://www.ncbi.nlm.nih.gov/pubmed/31636248
http://dx.doi.org/10.12659/AOT.918259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824191/
https://www.ncbi.nlm.nih.gov/pubmed/31636248
http://dx.doi.org/10.12659/AOT.918259

Ejemplares similares